Senzo is a deep-tech bio-med company developing testing products and IP.
Orphidia is developing a rapid blood diagnostic platform to simultaneously run common lab tests on a portable device.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 12, 2022 | Seed | $1.90M | 2 |
BioAdvance
Wellness Coaches USA |
— | Detail |
Jul 21, 2022 | Seed | $2M | 2 | BioAdvance | — | Detail |
Jan 22, 2018 | Seed | — | 1 | — | — | Detail |
May 1, 2017 | Seed | — | 2 | — | — | Detail |
Feb 12, 2016 | Convertable Note | — | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
BioAdvance | Yes | Seed |
Wellness Coaches USA | Yes | Seed |
Bossanova Investimentos | — | Seed |
Jay Zaveri | — | Seed |
Luigi Bajetti | — | Seed |
IndieBio | — | Convertable Note |
SOSV | — | Convertable Note |
Chris Sang | — | Convertable Note |